MicroRNA-26a deficiency attenuates the severity of frozen shoulder in a mouse immobilization model

Yasuhiko Sumimoto1, Yohei Harada1, Dilimulati Yimiti1

  • 1Department of Orthopaedic Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Insights

MicroRNA-26a (miR-26a) deficiency significantly reduced frozen shoulder severity in mice by decreasing inflammation and fibrosis. This suggests miR-26a is a potential therapeutic target for frozen shoulder treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Musculoskeletal Research

Background:

  • Frozen shoulder pathogenesis involves synovitis and joint capsule fibrosis, but molecular mechanisms remain unclear.
  • MicroRNAs, including microRNA-26a (miR-26a), are implicated in various diseases, with miR-26a linked to fibrosis in multiple organs.

Purpose of the Study:

  • To investigate the role of miR-26a in shoulder capsule fibrosis using a mouse model of frozen shoulder.
  • To evaluate the therapeutic potential of targeting miR-26a for frozen shoulder.

Main Methods:

  • Comparison of range of motion (ROM), histopathological changes (synovitis, fibrosis), and gene expression in immobilized wild-type (WT) and miR-26a deficient (miR-26a KO) mice.
  • Utilized an immobilization-induced frozen shoulder model in mice.

Main Results:

  • miR-26a KO mice demonstrated significantly better shoulder ROM and reduced histological severity compared to WT mice.
  • Inflammation- and fibrosis-related gene expression was notably decreased in miR-26a KO mice.
  • Immobilization led to synovitis and joint capsule thickening in WT mice, which was attenuated in miR-26a KO mice.

Conclusions:

  • miR-26a deficiency ameliorates frozen shoulder development in an immobilization model.
  • miR-26a plays a significant role in the pathogenesis of frozen shoulder.
  • miR-26a represents a promising miRNA target for developing novel therapeutic strategies for frozen shoulder.